Effects of danazol on steroidogenesis and gonadotropic responsiveness in isolated human preovulatory follicular cells

In order to investigate the influence of danazol on steroidogenesis and gonadotropic responsiveness of human follicular cells, granulosa and thecal cells of preovulatory follicles were isolated and separately incubated for short term periods. Human chorionic gonadotropin (hCG) (100 IU/ml), FSH (0.5 IU/ml) and danazol (10 μg/ml) alone or in combination were added to the incubation medium. Following incubation the cellular cyclic adenosine 3′5′ monophosphate (cAMP) levels and the medium content of progesterone (P), androstenedione (A) and 17β-estradiol (E2) were determined. All follicles included in the study were classified as nonatretic and well developed, i.e. less than 3 days before ovulation. Human chorionic gonadotropin caused an increase in cAMP formation in both celltypes and this effect was significantly counteracted by danazol in vitro. In granulosa cells danazol tended to counteract a stimulatory effect of FSH on cAMP formation. No significant influence of danazol was found on the basal steroid formation of both cell types during short term incubation. On the other hand, danazol significantly counteracted the FSH stimulated P formation of the granulosa cells and the hCG stimulated A and E2 formation of the thecal cells. It is concluded that danazol inhibits gonadotropin-stimulated steroidogenesis locally in the human follicular cells and that this effect of danazol is mediated via the cyclic AMP system. Similar content being viewed by others

Greenblatt R.B., Dmowski W.P., Mahesh V.B., Scholer H.F.L. Clinical studies with an antigonadotropin-danazol. Fertil. Steril. 22: 102, 1971. Dmowski W.P., Cohen M.R. Treatment of endometriosis with an antigonadotropindanazol. A laparoscopic and histologic evaluation. Obstet. Gynecol. 46: 147, 1975. Young M.D. The use of danazol in the management of endometriosis. J. Int. Med. Res. 5(Suppl. 3): 86, 1977. Ulstein M., Netto N., Leonard J., Paulsen C.A. Changes in sperm morphology in men treated with danazol and testosterone. Contraception 12: 437, 1975. Colle M.L., Greenblatt R.B. Contraceptive properties of danazol. J. Reprod. Med. 17: 98, 1976. Lauersen N.H. The effect of danazol in the treatment of chronic cystic mastitis. Obstet. Gynecol. 48: 93, 1976. Asch R.H. The use of an impeded androgen-danazol-in the management of benign breast disorders. Am. J. Obstet. Gynecol. 127: 130, 1977. Lee P.A., Thompson R.G., Migeon C.J., Blizzard R.M. The effects of danazol in sexual precocity. Johns Hopkins Med. J. 137: 265, 1975. Wood G.P., Wu C-H., Flickinger G.L., Mikhhail G. Hormonal changes associated with danazol therapy. Obstet. Gynecol. 45: 302, 1975. Guillebaud J., Fraser I.S., Thorburn G.D., Jenkin G. Endocrine effects of danazol in menstruating women. J. Int. Med. Res. 3(Supp. 5): 57, 1977. Barbieri R.L., Canik J.A., Makris A., Todd R.B., Davies I.J., Ryan K.J. Danazol inhibits steroidogenesis. Fertil. Steril. 28: 809, 1977. Menon M., Azhar S., Menon K.M.J. Evidence that danazol inhibits gonadotropin-induced steroidogenesis at a point distal to gonadotropin-receptor interaction and adenosine 3’, 5’ cycle monophosphate formations. Am. J. Obstet. Gynecol. 136: 524, 1980. Henderson K.M., Tsang B.K. Danazol suppresses luteal function in vitro and in vivo. Fertil. Steril. 33: 550, 1980. Milwidsky A., Besch N.F., Besch P.K., Kaufman R.H. Evidence of a possible direct action of danazol on the human ovary. Acta Obstet. Gynecol. Scand. 62: 187, 1983. McNatty K.P., Smith D.M., Makris A., Osathanondh R., Ryan K.J. The microenvironment of the human antral follicle: interrelationships among the steroid levels in antral fluid, the population of granulosa cells, and the status of the oocyte in vivo and in vitro. J. Clin. Endocrinol. Metab. 49: 851, 1979. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193: 265, 1951. Gilman A.G. A protein binding assay for adenosine 3’ 5’-cyclic monophosphate. Proc. Natl. Acad. Sci. USA 67: 305, 1970. Nilsson L., Dennefors B., Hamberger L. Granulosa and thecal cells from human ovarian follicles under growth: steroid formation in vitro and responsiveness to human chorionic gonadotropin. J. Endocrinol. Invest. 7: 323, 1984. Dennefors B.L., Nilsson L., Hamberger L. Steroid and adenosine 3’ 5’-monophosphate formation in granulosa and thecal cells from human preovulatory follicles in response to human chorionic gonadotropin. J. Clin. Endocrinol. Metab. 54: 2, 1982. Davidson C., Ross T.A.W., King M.E. Internal report. Sterling-Winthrop Research Institute, 1975. Dennefors B.L. Studies on the endocrine function of the human ovary. Experiments conducted on isolated ovarian compartments. Thesis ISBN 91-7222-423-1, University of Gothenburg, Sweden. Erickson G.F., Hsueh A.J.W., Quigley M.E., Rebar R.W., Yen S.S.C. Functional studies of aromatose activity in human granulosa cells from normal and polycystic ovaries. J. Clin. Endocrinol. Metab. 49: 514, 1979. Tsang B.K., Henderson K.M., Armstrong D.T. Effects of danazol on estradiol-17-β and progesterone secretion by porcine ovarian cells in vitro. Am. J. Obstet. Gynecol. 133: 256, 1979. Barbieri R.L., Canik J.A., Ryan K.J. Danazol inhibits steroidogenesis in the rat testis in vitro. Endocrinology 101: 1676, 1977. Stillman R.J., Ryan K.J. Danazol inhibits human adrenal 21 and 11-β-hydroxylation. Steroids 35: 251, 1980. Asch R.H., Fernandez E.O., Siler-Khodr T.M., Bartke A., Pauerstein C.J. Mechanism of induction of luteal phase defects by danazol. Am. J. Obstet. Gynecol. 136: 932, 1980. Author information Authors and Affiliations Rights and permissions About this article Cite this article Olsson, J.H., Dennefors, B. & Nilsson, L. Effects of danazol on steroidogenesis and gonadotropic responsiveness in isolated human preovulatory follicular cells. J Endocrinol Invest 9, 109–114 (1986). https://doi.org/10.1007/BF03348079 Received: Accepted: Published: Issue date: DOI: https://doi.org/10.1007/BF03348079